These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9756368)

  • 21. Antimicrobial expenditures and usage at four university hospitals. Baden-Württemberg Interuniversity Study Group.
    Kern WV; Rose AD; Hay B; Muche R; Frank U
    Infection; 2001; 29(3):127-37. PubMed ID: 11440382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost of antibiotic treatment for priority infectious syndromes in Paraguay, 2004.
    Baez E; Dentice MA; Heitmann I
    Epidemiol Bull; 2005 Jun; 26(2):8-11. PubMed ID: 16578882
    [No Abstract]   [Full Text] [Related]  

  • 23. Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals.
    Goff DA; Kullar R; Bauer KA; File TM
    Clin Infect Dis; 2017 Apr; 64(8):1134-1139. PubMed ID: 28203781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Special considerations for antimicrobial therapy in the elderly.
    Norman DC
    Geriatrics; 1989 Aug; 44 Suppl A():23-7. PubMed ID: 2777094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Realistic" antibiotic audit yields encouraging results.
    Drapkin M
    Hosp Infect Control; 1979 Feb; 6(2):19-20. PubMed ID: 10240087
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of the laboratory in choosing antibiotics.
    Coghe F; Orrù G; Pautasso M; Ferraguti P; Sanna P; Fanos V
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():18-20. PubMed ID: 21740333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technique for calculation of the true costs of antibiotic therapy.
    Kerr JR; Barr JG; Smyth ET; O'Hare J
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):823-7. PubMed ID: 1468420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an antibiotic intravenous to oral sequential therapy program.
    Pablos AI; Escobar I; Albiñana S; Serrano O; Ferrari JM; Herreros de Tejada A
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):53-9. PubMed ID: 15534901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for peer review. Veterans Administration Ad Hoc Interdisciplinary Advisory Committee on Antimicrobial Drug Usage.
    JAMA; 1977 Mar; 237(10):1001-2. PubMed ID: 319260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential antimicrobial therapy: comparison of the views of microbiologists and pharmacists.
    Smyth ET; Tillotson GS
    J Infect; 1998 Jul; 37 Suppl 1():18-23. PubMed ID: 9756365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modifiability of antibiotic use in a medical clinic].
    Bögli F; Pechula M; Mühlebach S; Conen D
    Schweiz Med Wochenschr; 1996 Nov; 126(48):2078-81. PubMed ID: 8992628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of sequential therapy programs--a microbiologist's view.
    Wilcox MH
    J Infect; 1998 Jul; 37 Suppl 1():51-4. PubMed ID: 9756370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy.
    Partsch DJ; Paladino JA
    Ann Pharmacother; 1997 Oct; 31(10):1137-45. PubMed ID: 9337437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Business aspects of infectious diseases.
    Tenenbaum MJ; Petrak R
    Clin Infect Dis; 2002 Feb; 34(3):420. PubMed ID: 11774093
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibiotic cost calculator; an expert system for global antibiotic cost calculation.
    Kerr J
    Comput Methods Programs Biomed; 1995 Jan; 46(1):13-21. PubMed ID: 7743776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
    PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of systemic antibiotics in seven community hospitals in Northern Israel.
    Raz R; Farbstein Y; Hassin D; Kitzes R; Miron D; Nadler A; Shimoni Z
    J Infect; 1998 Nov; 37(3):224-8. PubMed ID: 9892525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.